Wockhardt Ltd: Buy for superb returns! Face Value: Rs.5 CMP: Rs.212.40. Market Cap: Rs.3,012 crore. Market Cap: Rs.3059.84 crore. CEPS: Rs.2.22 Total Revenue in FY22: Rs.1,372.00 crore. Introduction : Wockhardt is a leading, research-based global healthcare enterprise, with interests in pharmaceuticals, biotechnology, and has a network of advanced Super Speciality Hospitals. Wockhardt is a true Indian MNC employing 8600 Associates from 21 different nationalities worldwide. It has 3 (three) research centers and 12 (twelve) manufacturing plants. Its products include pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs), and vaccines. Photo : Moneycontrol.com Wockhardt Hospitals, a subsidiary of Wockhardt Ltd, is an Indian tertiary care and super speciality healthcare network. These hospitals provide services in Cardiology, Orthopedics, Neurology, Gastroenterology, Urology, and other specialties. Photo : Live Mint. Wockhardt is headquartered in Mumba...